SPY317.05+4.82 1.54%
DIA263.00+4.58 1.77%
IXIC10,433.65+226.02 2.21%

Corcept Therapeutics Q3 EPS $0.31 Beats $0.2 Estimate, Sales $81.505M Beat $78M Estimate

Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.2 by 55 percent. This is a 40.91 percent increase over earnings of $0.22 per share from

Benzinga · -

Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.2 by 55 percent. This is a 40.91 percent increase over earnings of $0.22 per share from the same period last year. The company reported quarterly sales of $81.505 million which beat the analyst consensus estimate of $78 million by 4.49 percent. This is a 26.47 percent increase over sales of $64.445 million the same period last year.